Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A randomised, double-blind, placebo-controlled, Phase IIa pilot study to evaluate the safety, tolerability and efficacy of Lytixar™ (LTX-109) in patients with uncomplicated, Gram-positive, skin infection https://www.kusajili.fr:443/Trial/lTN6qJSGR0epFv-wyDdWZQ%24a-randomised-double-blind-placebo-controlled-phase-iia-pilot-study-to-evaluate-the-safety-tolerability-and-efficacy-of-lytixart
I have read and accept the terms of use of the site and the Privacy Policy
Send your message